Breast cancer and hormone-replacement therapy

Comment

K S Joseph. N Engl J Med. 1995.

. 1995 Nov 16;333(20):1356; author reply 1357-8.

No abstract available

Comment on

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. Colditz GA, et al. N Engl J Med. 1995 Jun 15;332(24):1589-93. doi: 10.1056/NEJM199506153322401. N Engl J Med. 1995. PMID: 7753136

Hormone replacement therapy and breast cancer risk.
Gambrell RD Jr. Gambrell RD Jr. Arch Fam Med. 1996 Jun;5(6):341-8. Arch Fam Med. 1996. PMID: 8640324 Review.
[Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
Brettes JP, Mathelin C. Brettes JP, et al. Gynecol Obstet Fertil. 2007 Nov;35(11):1092-4. doi: 10.1016/j.gyobfe.2007.09.003. Epub 2007 Nov 8. Gynecol Obstet Fertil. 2007. PMID: 17996474 French. No abstract available.
[Estrogen replacement therapy and breast cancer].
Bakken K, Alsaker E, Eggen AE, Lund E. Bakken K, et al. Tidsskr Nor Laegeforen. 2005 Feb 3;125(3):282-5. Tidsskr Nor Laegeforen. 2005. PMID: 15702147 Norwegian.
[Breast cancer risk with hormone replacement therapy. A matter of interpretation].
Röhm W. Röhm W. MMW Fortschr Med. 2004 Feb 5;146(6):15; author reply 15. MMW Fortschr Med. 2004. PMID: 15035307 German. No abstract available.
[Breast cancer and hormone replacement therapy].
Küng F, Maurer-Major E, Keller PJ. Küng F, et al. Schweiz Med Wochenschr. 1999 Apr 17;129(15):590-4. Schweiz Med Wochenschr. 1999. PMID: 10355020 Review. German.